NCT05718635 is a NA clinical trial of coloured duplex in Coverage of Soft Tissue Defects, sponsored by Aswan University.

Who is sponsoring NCT05718635?

NCT05718635 is sponsored by Aswan University.

What drugs are being tested in NCT05718635?

Interventions in NCT05718635: coloured duplex, supra facial dissection.

What condition does NCT05718635 study?

NCT05718635 studies Coverage of Soft Tissue Defects.

Is NCT05718635 still recruiting?

NCT05718635 is currently status unknown. Last updated 28 March 2023.

Last reviewed 2023-03-28 · How we verify

NCT05718635

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Perforator Mapping and Optimizing Design of the Lateral Arm Flap

Status unknown NA Last updated 28 March 2023

What this trial tests

NA trial testing coloured duplex in Coverage of Soft Tissue Defects in 30 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
26 March 2023

30 June 2023

Quick facts

Lead sponsor	Aswan University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	30
Start date	1 October 2020
Primary completion	26 March 2023
Estimated completion	30 June 2023
Sites	1 location across Egypt

Drugs / interventions tested

coloured duplex
supra facial dissection

Conditions studied

Coverage of Soft Tissue Defects — all drugs for Coverage of Soft Tissue Defects →

Sponsor

Aswan University

Who can join

16 and older, any sex, with Coverage of Soft Tissue Defects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to optimize the design of lateral arm flap. Colored duplex will be done for all Participants and compared to intra operative findings. flap modification (Supra facial) dissection to lateral arm flap will be done and the results will compared to the ordinary method of dissection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Aswan University trials

Trials by the same sponsor.

NCT07232238 — TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients · active not recruiting
NCT07140640 — Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Str · Phase 4 · not yet recruiting
NCT07466719 — Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Un · NA · recruiting
NCT07320872 — Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris · recruiting
NCT07109947 — Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05718635 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aswan University
Last refreshed: 28 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05718635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing